Solange Lavielle

Title: Solange Lavielle: Innovator in Glycosylated Analogs of Somatostatin

Introduction

Solange Lavielle is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biochemistry, particularly through her innovative work on glycosylated analogs of somatostatin. Her research focuses on enhancing the biological properties of peptides, which has important implications for medical science.

Latest Patents

Lavielle holds a patent for glycosylated analogs of somatostatin. This patent describes a modified version of somatostatin (SS) that incorporates a carbohydrate moiety into the peptide chain. The modifications allow for an extended biological half-life compared to the parent peptide while maintaining substantial potency. The glycosomatostatins developed by Lavielle can be linked to amino acids such as Asn, Ser, or Thr, and may include hexose or amino-hexose sugars like glucose or N-acetylglucosamine. These advancements in glycopeptides aim to increase the effectiveness of somatostatin analogs.

Career Highlights

Solange Lavielle is affiliated with the Salk Institute for Biological Studies, where she conducts her research. Her work has garnered attention for its potential applications in therapeutic settings, particularly in the treatment of various medical conditions.

Collaborations

Lavielle has collaborated with notable scientists in her field, including Roger C. Guillemin and Paul E. Brazeau, Jr. These collaborations have contributed to the advancement of research in peptide biology and its applications.

Conclusion

Solange Lavielle's innovative work on glycosylated analogs of somatostatin exemplifies the impact of scientific research on medicine. Her contributions continue to influence the field and pave the way for future advancements in peptide therapeutics.